Navigation Links
AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
Date:6/17/2013

e body fight infection. The cause of CLL is unknown, though researchers believe it may be linked to a genetic mutation.

About Non-Hodgkin's Lymphoma
Non-Hodgkin's lymphoma includes a diverse group of blood cancers that originates in lymphocytes, a type of white blood cell that is part of the body's immune system. NHL is the most common hematological cancer and the fifth leading cause of cancer death. In the EU, NHL affects approximately 90,000 to 138,000 people. 

Mantle cell lymphoma is an aggressive, rapidly progressive subtype of NHL. The median life expectancy for a patient with MCL following first relapse is one to two years.

About AbbVie Oncology
The fight against cancer is one of the greatest battles in medicine and the varied nature of the disease requires a diverse approach that looks at multiple disease targets in a variety of tumor types. AbbVie's oncology research is focused on the discovery and development of targeted therapies that work against the processes cancers need to survive. By investing in new technologies and approaches, we are breaking ground in some of the most widespread and difficult-to-treat cancers, including multiple myeloma and chronic lymphocytic leukemia. Our oncology pipeline includes multiple new molecules in clinical trials being studied in more than 15 different cancers and tumor types.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com.
'/>"/>

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AbbVie Named to S&P 500 Dividend Aristocrat Index
2. AbbVie Issues Inaugural Full-Year Outlook for 2013
3. AbbVie to Present at Barclays Global Health Care Conference
4. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
5. AbbVie to Host First-Quarter Earnings Conference Call
6. AbbVie Reports First-Quarter 2013 Financial Results
7. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
8. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
9. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
10. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
11. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... will be participating in the Goldman Sachs 2015 European ... in London on Thursday, September ... 1927 and headquartered in Warsaw, Indiana ... healthcare.  We design, manufacture and market orthopaedic reconstructive products; ...
(Date:8/27/2015)... 27, 2015 WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology, and ... development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical ... from the Japan PMDA for the manufacture ... commercial drug in July. STA is now ...
(Date:8/27/2015)... , Aug. 27, 2015  Symbiomix today announced ... clinical study, the second pivotal trial of SYM-1219, which ... of bacterial vaginosis (BV). Earlier this year Symbiomix announced ... Symbiomix expects to finish this second pivotal trial by ... Drug Application (NDA) filing with the U.S. Food and ...
Breaking Medicine Technology:WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 3Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 4
... Texas, July 21, 2011 Assured Pharmacy, Inc. (Other ... medications to more than 3,000 sufferers of chronic pain, ... Pink Current Information with the OTC Markets, using the ... have been posted on the OTC Markets website and ...
... N.J., July 20, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... financial results for the second quarter 2011 prior to the ... John H. Johnson, Chief Executive Officer and President, ... will host an investment community conference call beginning at 9:00 ...
Cached Medicine Technology:Assured Pharmacy Upgrades to OTC Pink Current Information 2Assured Pharmacy Upgrades to OTC Pink Current Information 3Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011 2
(Date:8/27/2015)... Angeles, CA (PRWEB) , ... August 27, 2015 , ... ... that the helpfulness of a doctor is tied directly to the success of a ... patients over a two year period, measured their weight loss over that period, and ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... In ... get help, leaving weeks or months later, relapsing and returning again, all at great ... the influence while in sober living homes or soon after leaving facilities who claim ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... instruments available for quantitative PCR (qPCR) in the last decade. New ... and reduced operating costs. On the flipside, where do lab managers, technicians, and ...
(Date:8/27/2015)... ... August 27, 2015 , ... According to an ... Heart Association have released new guidelines to educate doctors and patients on the best ... these particular guidelines came in 2007, so the new version is taking into account ...
(Date:8/27/2015)... ... 27, 2015 , ... Thriveology Founders, Dr. Carly Letzt Carney and Dr. Mark ... Expo in Denver, Colorado on Saturday, August 29, 2015 at the Marriott DTC, 4900 ... as health authorities, and will present a two part seminar entitled, “How to Thrive ...
Breaking Medicine News(10 mins):Health News:Article on Physician Influence on Weight Loss Highlights the Importance of a Doctor Who Cares, says Dr. Feiz & Associates 2Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 2Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 3Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2
... Drug resistance is making many diseases increasingly difficult--and ... M.D., director of the National Institute of Allergy ... Institutes of Health. Extensively drug-resistant tuberculosis and invasive ... recent examples of this problem that pose serious ...
... Week March,10 - 17 unites MS organizations and all ... an effort to shine a spotlight on ways,that we ... someone is,newly diagnosed each hour., (Logo: http://www.newscom.com/cgi-bin/prnh/20010328/NEW004LOGO ... To Join The MS Movement, The National Multiple ...
... APA,s Psychologically Healthy Workplace Awards, ... Nine Honored for Best Practices, ... and making ends meet, three-fourths of Americans,say they are stressed ... of employees reap rewards for employer and employees alike,including benefits ...
... A study by the Woolcock Institute of Medical Research in ... very mild or well-controlled asthma, regular treatment with low dose ... , The study published in this months edition of Primary ... and compared the effects of inhaled corticosteroids (ICS) and placebo ...
... possible to take a simple blood test and predict whether ... predisposing them to the development of Type 2 diabetes. If ... use preventative treatment, slowing down, or even halting that development. ... Sydneys Garvan Institute of Medical Research who have shown conclusively ...
... Essman, Will Ferrell, Tina Fey, Jonah Hill, Kevin James,Conan O,Brien, Rosie O,Donnell, Amy ... Insult Comic Dog And Many More To Be Announced ,Night Of ... $1.99 For 30 Days After Airdate With All Proceeds Going To ... Autism ...
Cached Medicine News:Health News:Confronting the challenge of antimicrobial resistance 2Health News:Confronting the challenge of antimicrobial resistance 3Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 2Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 3Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 4Health News:Top Employers Show Investing In Health and Well-Being Leads to Business Success 2Health News:Top Employers Show Investing In Health and Well-Being Leads to Business Success 3Health News:Top Employers Show Investing In Health and Well-Being Leads to Business Success 4Health News:Treatment for mild asthma leads to improved lung function 2Health News:Low levels of PYY hormone a very early indicator of type 2 diabetes 2Health News:COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 2Health News:COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 3
... latest addition to the HemoCue glucose product range. ... combines the precision and accuracy of a laboratory ... ease of use. The new pocket size analyser ... date and time for up to 600 measurements. ...
ELISA for the detection of C. difficile toxin A in stool specimens...
... should not suffice, then electronic magnification comes into ... set today. With an electronic television reader, text, ... 70 times. A video camera shows a recorded ... monitor. The television reader has been especially developed ...
... combination of topography, auto-refraction and keratometer in ... devices. The compactness of this instrument is ... space and cost saving solution. Highly ... time and easy handling makes working with ...
Medicine Products: